Connect with us

Healthcare

CDC: Fully vaccinated people can travel again, should still take precautions

Published

on

Screen Shot 2020 11 03 at 11.30.29 AM

Fully vaccinated people can safely travel domestically and abroad again, the Centers for Disease Control and Prevention (CDC) announced in new guidance on Friday.

“Fully vaccinated travelers are less likely to get and spread COVID-19,” the guidance said.

At a Friday briefing, CDC Director Rochelle Walensky emphasized that the agency still urges that “all travelers, regardless of vaccination status, should continue to wear masks on planes buses, trains, and other forms of public transportation, while traveling.”

Those traveling within the United States, according to the CDC, don’t need to get a COVID-19 test before or self-quarantine after a trip.

Regarding overseas travel, fully vaccinated people don’t need a test beforehand unless their destination country requires it and don’t have to self-quarantine upon returning to the U.S.

Walensky on Friday also cautioned that fully vaccinated individuals who are traveling abroad should still get tested three to five days after returning the U.S.

The agency deems someone fully vaccinated two weeks after receiving the final required dose of a COVID-19 vaccine. The new guidance, it should be noted, does not apply to unvaccinated individuals. For those not fully vaccinated, the CDC urges them to keep refraining from travel.

You can follow Douglas Braff on Twitter @DouglasPBraff.

You may like

Continue Reading

Healthcare

TN Republican introduces legislation to fight opioid shipments into U.S.

Published

on

Fentanyl 1031234188 scaled

Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:

The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.

“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”

“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.

The Daily Caller reports:

According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.

The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.

Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC